百花医药：2025年半年度净利润约2548万元，同比增加12.45%

Core Viewpoint - Baihua Pharmaceutical reported a year-on-year increase in revenue and net profit for the first half of 2025, indicating stable growth in its financial performance [2] Financial Performance - The company's operating revenue for the first half of 2025 was approximately 202 million yuan, representing a year-on-year increase of 2.95% [2] - The net profit attributable to shareholders was around 25.48 million yuan, reflecting a year-on-year increase of 12.45% [2] - Basic earnings per share were 0.0663 yuan, which is an increase of 11.62% compared to the previous year [2]